May 6, 2021

    Qorvo Biotechnologies is focused on the development of point-of-care (POC) diagnostics solutions. Our detection system represents a paradigm shift in diagnostic testing capability: based on Qorvo’s high performance bulk acoustic wave (BAW) sensor technology, it enables low Limit of Detection (LOD) levels that are similar to molecular testing capability. The platform is designed with the goal to deliver accurate results in approximately 20 minutes. April 2021 UPDATE: Please visit to read the latest news regarding our work in veterinary and human testing, and our authorization from the FDA under the EUA process.